{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:16:04Z","timestamp":1790795764367,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ctro.2025.101037","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:59:45Z","timestamp":1756223985000},"page":"101037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Salvage stereotactic MR-Guided adaptive radiotherapy (SMART) re-irradiation for locally recurrent prostate Cancer: Clinical and dosimetric outcomes"],"prefix":"10.1016","volume":"56","author":[{"given":"Elena","family":"Moreno-Olmedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1059-9742","authenticated-orcid":false,"given":"Dan","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prantik","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7485-4694","authenticated-orcid":false,"given":"Ami","family":"Sabharwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoodhvir","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yae-eun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Camilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ctro.2025.101037_b0005","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"International Journal of Radiation Oncology*biology*physics"},{"issue":"6","key":"10.1016\/j.ctro.2025.101037_b0010","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.juro.2015.06.100","article-title":"Anatomical patterns of Recurrence following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer","volume":"194","author":"Zumsteg","year":"2015","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.ctro.2025.101037_b0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.urolonc.2013.12.014","article-title":"Underutilization of local salvage therapy after radiation therapy for prostate cancer11Funding: UBC Summer Student Research Program","volume":"32","author":"Tran","year":"2014","journal-title":"Urologic Oncology: Seminars and Original Investigations"},{"issue":"11","key":"10.1016\/j.ctro.2025.101037_b0020","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1016\/S1470-2045(17)30774-X","article-title":"Timing of androgen-deprivation therapy in prostate cancer","volume":"18","author":"Del Priore","year":"2017","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101037_b0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncr.23161","article-title":"Treatment failure after primary and salvage therapy for prostate cancer","volume":"112","author":"Agarwal","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ctro.2025.101037_b0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on Prostate Cancer\u20142024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ctro.2025.101037_b0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A Systematic Review and Meta-analysis of Local Salvage Therapies after Radiotherapy for Prostate Cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.ctro.2025.101037_b0040","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00066-017-1157-2","article-title":"High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy","volume":"193","author":"Chatzikonstantinou","year":"2017","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101037_b0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijrobp.2016.05.024","article-title":"Reirradiation of Prostate Cancer local failures after previous Curative Radiation Therapy: Long-Term Outcome and Tolerance","volume":"96","author":"Zilli","year":"2016","journal-title":"International Journal of Radiation Oncology*biology*physics"},{"issue":"5","key":"10.1016\/j.ctro.2025.101037_b0050","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.adro.2020.04.022","article-title":"A Novel Salvage Option for local failure in Prostate Cancer, Reirradiation using External Beam or Stereotactic Radiation Therapy: Systematic Review and Meta-Analysis","volume":"5","author":"Corkum","year":"2020","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101037_b0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijrobp.2019.10.014","article-title":"Retreatment for Local Recurrence of Prostatic Carcinoma after prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT","volume":"106","author":"Fuller","year":"2020","journal-title":"International Journal of Radiation Oncology*biology*physics"},{"key":"10.1016\/j.ctro.2025.101037_b0060","first-page":"11","article-title":"Salvage Reirradiation Options for locally Recurrent Prostate Cancer: a Systematic Review","volume":"9","author":"Zhong","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2025.101037_b0065","article-title":"Re-irradiation to the prostate using stereotactic body radiotherapy (SBRT) after initial definitive radiotherapy \u2013 a systematic review and meta-analysis of recent trials","volume":"48","author":"Schr\u00f6der","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"issue":"16","key":"10.1016\/j.ctro.2025.101037_b0070","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.23.01391","article-title":"Salvage Reirradiation for locally Recurrent Prostate Cancer: results from a prospective Study with 7.2 Years of Follow-up","volume":"42","author":"Ekanger","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101037_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102206","article-title":"Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: an ESTRO ACROP Delphi consensus","volume":"98","author":"Jereczek-Fossa","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctro.2025.101037_b0080","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.6_suppl.255","article-title":"Magnetic resonance imaging-guided versus computed tomography-guided stereotactic body radiotherapy for prostate cancer (MIRAGE): Interim analysis of a phase III randomized trial","author":"Kishan","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101037_b0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/0284186X.2020.1821090","article-title":"Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy","volume":"60","author":"Nicosia","year":"2021","journal-title":"Acta Oncol (madr)"},{"issue":"8","key":"10.1016\/j.ctro.2025.101037_b0090","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/cancers14081943","article-title":"Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical results of a prospective Registry Study","volume":"14","author":"Michalet","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctro.2025.101037_b0095","article-title":"1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: a Preliminary Report of Toxicity and Clinical Outcomes. Front","author":"Cuccia","year":"2022","journal-title":"Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101037_b0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13014-023-02271-y","article-title":"Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis","volume":"18","author":"Boldrini","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101037_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109631","article-title":"The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial","volume":"183","author":"Nikitas","year":"2023","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2025.101037_b0110","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","article-title":"Hydrogel Spacer prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetricand Clinical Effects of Perirectal Spacer Application in Men Undergoing ProstateImage Guided Intensity Modulated RadiationTherapy","volume":"92","author":"Mariados","year":"2015","journal-title":"International Journal of Radiation Oncology*biology*physics"},{"key":"10.1016\/j.ctro.2025.101037_b0115","unstructured":"NHS England. Clinical Commissioning Policy: stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent primary pelvic tumours (all ages) 2021. [Internet]. [cited 2025 Jan 17]. Available from: https:\/\/www.england.nhs.uk\/publication\/clinical-commissioning-policy-stereotactic-ablative-radiotherapy-sabr-for-patients-with-previously-irradiated-locally-recurrent-primary-pelvic-tumours-all-ages\/."},{"key":"10.1016\/j.ctro.2025.101037_b0120","doi-asserted-by":"crossref","unstructured":"Moreno-Olmedo E, Owczarczyk K, Chadwick E, Dickinson P, Duffton A, Jones B, et al. Pelvic stereotactic ablative body radiotherapy (SABR) reirradiation: UK SABR consortium guidance for use in routine clinical care. Tech Innov Patient Support Radiat Oncol. 2025 Aug;100326.","DOI":"10.1016\/j.tipsro.2025.100326"},{"key":"10.1016\/j.ctro.2025.101037_b0125","series-title":"Basic Clinical Radiobiology","author":"Joiner","year":"2009"},{"key":"10.1016\/j.ctro.2025.101037_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110184","article-title":"Multi-centre evaluation of variation in cumulative dose assessment in reirradiation scenarios","volume":"194","author":"Hardcastle","year":"2024","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2025.101037_b0135","doi-asserted-by":"crossref","first-page":"196","DOI":"10.5603\/RPOR.a2021.0028","article-title":"Comparative dosimetrical analysis of intensity-modulated arc therapy, CyberKnife therapy and image-guided interstitial HDR and LDR brachytherapy of low risk prostate cancer","volume":"26","author":"Fr\u00f6hlich","year":"2021","journal-title":"Reports of Practical Oncology and Radiotherapy"},{"issue":"15","key":"10.1016\/j.ctro.2025.101037_b0140","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer","volume":"391","author":"van As","year":"2024","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ctro.2025.101037_b0145","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S1470-2045(22)00447-8","article-title":"European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making","volume":"23","author":"Andratschke","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2025.101037_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111030","article-title":"Reirradiation dose constraints in clinical practice: results of an international survey","volume":"210","author":"Stroom","year":"2025","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2025.101037_b0155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/srao.2000.6593","article-title":"Tissue tolerance to reirradiation","volume":"10","author":"Nieder","year":"2000","journal-title":"Semin Radiat Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2025.101037_b0160","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.clon.2020.07.023","article-title":"Complex Clinical Decision-making Process of Re-Irradiation","volume":"32","author":"Armstrong","year":"2020","journal-title":"Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2025.101037_b0165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ctro.2025.101037_b0170","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.euo.2021.01.003","article-title":"Prostate magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based guidelines on Multiparametric magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy","volume":"4","author":"Panebianco","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ctro.2025.101037_b0175","article-title":"Prostate Imaging for Recurrence Reporting: User Guide","author":"Shetty","year":"2025","journal-title":"Radiographics"},{"key":"10.1016\/j.ctro.2025.101037_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-020-01510-w","article-title":"1.5\u2009T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment","author":"Alongi","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2025.101037_b0185","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.radonc.2021.03.025","article-title":"ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology","volume":"159","author":"Corradini","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2025.101037_b0190","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.6_suppl.255","article-title":"Magnetic resonance imaging-guided versus computed tomography-guided stereotactic body radiotherapy for prostate cancer (MIRAGE): Interim analysis of a phase III randomized trial","author":"Kishan","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101037_b0195","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.5_suppl.419","article-title":"Decipher risk stratification of radiorecurrent prostate cancer: Correlative analysis of the F-SHARP trial of salvage reirradiation","author":"Solanki","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2025.101037_b0200","first-page":"202","article-title":"Ongoing prospective studies on reirradiation: a systematic review of a clinical trials database","volume":"1","author":"Willmann","year":"2025","journal-title":"Radiother Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:35:09Z","timestamp":1787729709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630825001296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"alternative-id":["S2405630825001296"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101037","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage stereotactic MR-Guided adaptive radiotherapy (SMART) re-irradiation for locally recurrent prostate Cancer: Clinical and dosimetric outcomes","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101037"}}